In Gene Patent Ruling, SCOTUS Draws Line Between Product of Nature and Invention | GenomeWeb

Originally published June 14.

It may have taken enormous effort and investment to isolate specific gene mutations and discover their links to disease, and the US Patent and Trademark Office may have long granted IP protection for claims on such isolated DNA fragments, but neither of these facts convinced the US Supreme Court to uphold Myriad Genetics' patents on BRCA1 and BRCA2 genes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.